- Home
- IDYA vs YELP Comparison
IDYA vs YELP Comparison
Compare IDYA & YELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- YELP
- Stock Information
- Founded
- IDYA 2015
- YELP 2004
- Country
- IDYA United States
- YELP United States
- Employees
- IDYA N/A
- YELP N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- YELP Other Consumer Services
- Sector
- IDYA Health Care
- YELP Consumer Discretionary
- Exchange
- IDYA Nasdaq
- YELP Nasdaq
- Market Cap
- IDYA 2.3B
- YELP 2.0B
- IPO Year
- IDYA 2019
- YELP 2012
- Fundamental
- Price
- IDYA $26.88
- YELP $31.64
- Analyst Decision
- IDYA Buy
- YELP Hold
- Analyst Count
- IDYA 15
- YELP 5
- Target Price
- IDYA $47.92
- YELP $34.00
- AVG Volume (30 Days)
- IDYA 1.2M
- YELP 858.2K
- Earning Date
- IDYA 11-03-2025
- YELP 11-06-2025
- Dividend Yield
- IDYA N/A
- YELP N/A
- EPS Growth
- IDYA N/A
- YELP 16.67
- EPS
- IDYA N/A
- YELP 2.19
- Revenue
- IDYA $7,000,000.00
- YELP $1,451,224,000.00
- Revenue This Year
- IDYA $63.41
- YELP $6.16
- Revenue Next Year
- IDYA $305.49
- YELP $3.87
- P/E Ratio
- IDYA N/A
- YELP $14.42
- Revenue Growth
- IDYA N/A
- YELP 5.37
- 52 Week Low
- IDYA $13.45
- YELP $29.96
- 52 Week High
- IDYA $32.67
- YELP $41.72
- Technical
- Relative Strength Index (RSI)
- IDYA 59.69
- YELP 43.47
- Support Level
- IDYA $26.77
- YELP $30.90
- Resistance Level
- IDYA $28.41
- YELP $32.93
- Average True Range (ATR)
- IDYA 0.92
- YELP 0.66
- MACD
- IDYA 0.04
- YELP 0.06
- Stochastic Oscillator
- IDYA 59.24
- YELP 11.36
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.